secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch Health Companies Inc. (BHC)
CIK:        0000885590
Form:       8-K
Filed at:   2023-09-11T23:59:59+00:00
Accession:  0001193125-23-232026
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb launches $1.4B notes offering and $500M term loan for XIIDRA acquisition
--------------------------------------------------------------------------------

- Bausch + Lomb Escrow Corp. launched $1.4B senior secured notes due 2028; Bausch + Lomb seeks $500M incremental term B loan.
- Net proceeds to fund XIIDRA acquisition, fees, expenses, and general corporate purposes including debt repayment.
- Notes offering not conditioned on acquisition close; if not closed by Sept 30, 2024, notes redeemed at par plus accrued interest.
- Preliminary purchase price allocation adjustments: prepaid assets reduced $22M, non-current liabilities reduced $12M, goodwill increased $10M.
- Adjustments reduced amortization expense by $43M for FY2022 and $20M for six months ended June 2023; no impact on revenue or Adj. EBITDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885590/000119312523232026/0001193125-23-232026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885590/000119312523232026/d528926d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-232026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer